Submit Manuscript  

Article Details


MiRNA-based Therapeutics for Lung Cancer

[ Vol. 23 , Issue. 39 ]

Author(s):

Miaowei Wu*, Guosheng Wang*, Wei Tian, Yongchuan Deng and Yibing Xu   Pages 5989 - 5996 ( 8 )

Abstract:


Background: miRNA, a small non-coding RNA molecule containing about 22 nucleotides, functions in RNA silencing and post-transcriptional regulation of gene expression. With these qualities, miRNAs modulate multiple signaling pathways involved in cancer development, such as cellular proliferation, apoptosis, and migration.

Methods: The goal of this review is to discuss possible miRNAs-based therapeutic strategies, through defining performance of miRNAs in carcinogenesis, in particular in lung cancer.

Results: miRNA, a non-coding RNA, is divided into two main types: tumor suppressor miRNAs and oncogenic miRNAs. In addition, special processed miRNAs can be an assistant therapeutic tool.

Conclusion: In order to develope antitumor therapy, miRNAs-based therapeutic strategies are worth of deeper studies. In this process, the stability, effectiveness, and side effects should be considered.

Keywords:

miRNA, oncogene, tumor suppressor, drug resistance, lung cancer, therapy.

Affiliation:

Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Surg Oncol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou 310029, Zhejiang, Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Surg Oncol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Surg Oncol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Zhejiang Univ, Sch Med, Inst Translat Med, Hangzhou 310029, Zhejiang



Read Full-Text article